How did this first-of-its-kind platform trial tackle ALS's debilitating disease progression and what can other rare disease study teams learn from it?
Firma's Dr. D.J. Tang shares in a Clinical Researcher article insights on effective data analysis for nontraditional study designs.
More and more global clinical trials are using a hybrid approach to study visits. Find out the biggest challenges--and how to solve them.
What sites and study teams really want to know about using remote, in-home visits as part of their clinical trial protocols. The answers to the most common questions.
Nikki Skirvin was interviewed by Jenni Spinner about multi-national studies in an article for Outsourcing Pharma earlier this year.